Allan Will, Chairman of the Board, President & CEO – Allan is an operating executive with extensive experience founding, funding, operating, and selling medical device companies. Prior to EBR, he led negotiation of Ardian’s acquisition by Medtronic for over $800M. Will was also founding Managing Director, Split Rock Partners and a Partner at St. Paul Venture Capital. Previously, he was Founder, Chairman & CEO of The Foundry, co-founding 11 companies there including Ardian, Evalve (acquired by Abbott Laboratories for $450M) & Concentric Medical (acquired by Stryker for $135M). Previously, Will was CEO of AneuRx, acquired by Medtronic, growing to >$150MM the year of launch. In 1996 Will co-founded Adjacent Surgical, sold to GSII. Previously, he was President & CEO of Devices for Vascular Intervention, growing the business to 550 employees, $100MM revenue run rate, and acquisition by Eli Lilly. Will is an inventor on more than 30 issued patents, and has his M.S. in Management from MIT and his B.S. in Zoology from University of Maryland. Will has also served on MIT’s Entrepreneurship Center Shareholders Board, on the University of Maryland President’s Committee on Innovation and Entrepreneurship and is a University of Maryland “Distinguished Alumnus”. Will was the recipient of the Astia/Deloitte Leadership in Mentoring Award for mentoring women executives.
Chairman of the Board,
President & CEO
Rick Riley, COO, Co-Founder & Director – Rick has an extensive medical device development background with experience in a wide range of devices used in electrophysiology including pacemakers, defibrillators, CRM programmers, catheters, ablation energy technologies, and imaging and electro-mapping systems. He brings a strong management background to the team, including executive positions at Boston Scientific, Cardiac Pathways and Medtronic and as the Founding CEO of EBR Systems. Riley is an inventor on more than 25 issued patents, and has his M.S. in Industrial and Management System Engineering from Arizona State University and his B.S. in Computer Science from University of Kansas.
COO, Co-Founder & Director
Mark Cowan, Vice President of Engineering – Mark is an Electrical Engineer with over 35 years of successful development experience in R&D leadership for medical instrumentation and systems. He has completed devices from conception to market for both diagnostic and therapeutic use. He brings a strong technical and management background to the team, including executive positions at Pharmasonics, Cardiometrics and Diasonics. Cowan is an inventor on more than 30 issued patents, and has his B.S. in Electrical Engineering from the University of the Pacific, Stockton.
Vice President of Engineering
Andrew Shute, Vice President of Europe – Andrew has over 20 years of medical device experience and has led the successful commercialization of new technologies and products working in the corporate, start-up and distributor settings. He brings strong business, clinical training and sales management background to the team, including positions at St. Jude Medical, Endocardial Solutions and Getz Brothers. Shute received his B.S. from the University of Wollongong, Australia. Shute currently holds the position of Chairman of the Cardiac Rhythm Management section of the Association of British Healthcare Industries Ltd (ABHI).
Vice President of Europe
Mark Schwartz, Vice President of Clinical and Regulatory Affairs – Mark has over 20 years of experience in the medical device industry and has proven leadership in the design and execution of clinical studies. He brings strong clinical study design and execution background to the team, including positions at The Sorin Group, Boston Scientific, Guidant, InControl and Intermedics. Schwartz is an inventor on more than 15 issued patents, and has his B.S. in Electrical Engineering from North Dakota State University and his M.S. in Biomedical Engineering from the University of Texas, Arlington.
Vice President of Clinical & Regulatory Affairs
N. Parker Willis, Ph.D., Chief Technical Officer – Parker is an electrical engineer with extensive experience in signal processing applications and has worked in medical devices for over 20 years, all in technical leadership capacities for development of novel technologies for cardiac electrophysiology. He previously held senior positions at Boston Scientific and Cardiac Pathways. Willis is an inventor on more than 28 issued patents, and has his B.Sc. in Electrical Engineering from the University of California, San Diego and his M.Sc. and Ph.D. from the University of Illinois Urbana Champaign.
N. Parker Willis, Ph.D.
Chief Technical Officer